Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
BRAWN
BRAWN

Brawn Biotech Ltd.

BSE: 530207
Sector: Healthcare
Industry: Pharmaceuticals
25.40+0.0 (+0.00%)
21 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
7.62
P/E (TTM)
8.10
P/B
1.76
P/S (TTM)
0.44
EV/EBITDA
-
CAPE (5Y)
-
ROE (TTM)
24.43
ROCE (TTM)
-11.64
ROA (TTM)
4.55
Avg 3Y ROE
-12.93
Earnings 3Y CAGR
-
Sales 3Y CAGR
-12.90
Sales 5Y CAGR
-
Debt/Equity
0.00
Consensus TP
-
Strong Buy %
-
Promoter Holding
52.94
Pledged %
0.00

Share Price

Track Brawn Biotech Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

25.400.0 (0.00%) D
26.05% in past 1 year
1 Week returns: 9.01 %
Low
23.5
High
25.4
1 Month returns: 17.27 %
Low
21.4
High
25.7
1 Year returns: 31.95 %
Low
17.7
High
25.7
3 Year CAGR: -
Low
14.6
High
27.8
5 Year CAGR: 2.45 %
Low
13.6
High
27.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Brawn Biotech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 8.1 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -73.42%

What is P/E Ratio?

Median: 30.47
Value 8.1
-0.82614.73
Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.000960244.

Financial Snapshot

See detailed analysis

Multi-year trends for Brawn Biotech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k0k22.2 CrMar 202316.5 CrMar 202413.5 CrMar 202517.0 CrMar 2026
Profit After Tax FY
-0k-0k-0k-0k00k0k-0.9 CrMar 2023-1.2 CrMar 2024-1.8 CrMar 20250.9 CrMar 2026
ROE FY
-60%-40%-20%0%20%40%-21.9%Mar 2024-41.3%Mar 202524.4%Mar 2026
EBITDA FY
-0k-0k-0k-0k0-0.3 CrMar 2023-1.5 CrMar 2024-1.8 CrMar 2025-0.3 CrMar 2026

Brawn Biotech Ltd. Shareholding Pattern

Quarterly breakdown of Brawn Biotech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Promoter
53.71
53.71
53.71
53.71
53.71
53.71
53.71
53.71
53.71
53.73
53.73
53.72
53.72
53.72
53.72
53.72
53.64
53.64
53.64
53.64
53.66
53.66
53.66
53.39
52.94
52.94
52.94
Indian Promoter
53.71
53.71
53.71
53.71
53.71
53.71
53.71
53.71
53.71
53.73
53.73
53.72
53.72
53.72
53.72
53.72
53.64
53.64
53.64
53.64
53.66
53.66
53.66
53.39
52.94
52.94
52.94
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
Mutual Funds / UTI
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.59
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
45.69
45.69
45.69
45.69
45.69
45.69
45.69
45.69
45.69
45.68
45.68
45.69
45.69
45.69
45.69
45.69
46.01
46.01
46.01
46.01
45.99
45.99
45.99
46.26
46.71
46.71
46.71
Bodies Corporate
0.46
0.46
0.47
0.47
0.47
0.47
0.47
0.46
0.58
0.58
0.58
0.58
0.57
0.57
0.57
0.57
0.42
0.42
0.38
0.38
0.38
0.38
0.38
0.38
0.28
0.28
0.28
Others (incl. Retail)
No. of shareholders
45.23
6,018
45.23
6,021
45.22
6,025
45.22
5,990
45.22
5,937
45.22
5,907
45.22
5,944
45.23
6,030
45.11
6,235
45.10
6,231
45.10
6,228
45.11
6,222
45.12
6,170
45.12
6,194
45.12
6,142
45.12
6,087
45.59
4,118
45.59
4,048
45.63
4,115
45.63
4,018
45.61
3,982
45.61
3,932
45.61
3,915
45.88
3,405
46.43
3,266
46.43
3,247
46.43
3,225

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Brawn Biotech Ltd. shares as reported to NSE and BSE.

NameDateTypePriceQty.Value
Naimabbas Anvarali Jamani20 Dec 2024buy₹ 22.7617.65 k₹ 4.02 lac
Naimabbas Anvarali Jamani20 Dec 2024sell₹ 22.502.00 k₹ 45.00 k

Corporate Actions

History of Brawn Biotech Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Dividend₹ 1/share
    Record date: 14th Sep 2018Ex-date: 12th Sep 2018
    Announced on: 29th May 2018
  2. Dividend₹ 1.50/share
    Record date: 15th Sep 2017Ex-date: 14th Sep 2017
    Announced on: 29th May 2017

Company Profile

Overview of Brawn Biotech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Brawn Biotech Limited is an India-based integrated healthcare company. The Companys pharmaceutical products cover all product segments, such as Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarial...
Key personnel
Ms. Priyanka Sharma
Compliance Officer, Company Secretary
Mr. Amit Kumar
Manager
Mr. Mayank JainD
Additional Non-Executive Independent Director
Mrs. Pooja JhaD
Additional Non-Executive Independent Director
Mrs. Pooja JhaD
Additional Non-Executive Independent Director
Mrs. Pooja JhaD
Additional Non-Executive Independent Director
Mrs. Pooja JhaD
Additional Non-Executive Independent Director
Incorporated on
07 Nov 1985
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
-
IPO date
06 Mar 1995
Free Float
9,42,291
Phone no.
+911129815331
Address
C-64, Lajpat Nagar - 1, NEW DELHI, 110024, India

Frequently Asked Questions

What is the current share price of Brawn Biotech Ltd.?
The current share price of Brawn Biotech Ltd. is ₹ 25.40 as of 21 Oct 2026.
What is the market capitalisation of Brawn Biotech Ltd.?
The market capitalisation of Brawn Biotech Ltd. stands at ₹ 7.62 Cr.
What is the PE ratio of Brawn Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Brawn Biotech Ltd. is 8.10 as of the latest trailing twelve months data.
What is the ROE and ROCE of Brawn Biotech Ltd.?
Brawn Biotech Ltd. has a Return on Equity (ROE) of 24.43% and a Return on Capital Employed (ROCE) of -11.64% as per the latest financial reports.
What is the 52-week high and low of Brawn Biotech Ltd.?
The 52-week high of Brawn Biotech Ltd. is - and the 52-week low is -.
What is the dividend yield of Brawn Biotech Ltd.?
The dividend yield of Brawn Biotech Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Brawn Biotech Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.35% and retail/public investors hold 46.43% of Brawn Biotech Ltd. shares.
What sector does Brawn Biotech Ltd. belong to?
Brawn Biotech Ltd. operates in the Healthcare sector.
What is the beta of Brawn Biotech Ltd.?
The beta of Brawn Biotech Ltd. is 0.11, indicating its price volatility relative to the broader market.
What is the RSI of Brawn Biotech Ltd.?
The 14-day Relative Strength Index (RSI) of Brawn Biotech Ltd. is 61.64, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.